SOTAC — Sotac Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual balance sheet for Sotac Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.37	0.276	96	34.2	22.5
Net Total Accounts Receivable
Net Total Receivables	60.5	149	115	265	441
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	173	259	366	606	698
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	166	87.9	141	336	468
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	347	353	548	1,053	1,243
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	228	276	271	437	515
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	322	286	433	601	711
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	24.9	66.2	115	453	533
Total Liabilities & Shareholders' Equity	347	353	548	1,053	1,243
Total Common Shares Outstanding